These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28365448)

  • 41. Synthesis of NBD-alpha-galactosylceramide and its immunologic properties.
    Sakai T; Ehara H; Koezuka Y
    Org Lett; 1999 Aug; 1(3):359-61. PubMed ID: 10822576
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activation of Invariant Natural Killer T Cells Redirects the Inflammatory Response in Neonatal Sepsis.
    Bolognese AC; Yang WL; Hansen LW; Sharma A; Nicastro JM; Coppa GF; Wang P
    Front Immunol; 2018; 9():833. PubMed ID: 29720984
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis and evaluation of acyl-chain- and galactose-6''-modified analogues of α-GalCer for NKT cell activation.
    Hsieh MH; Hung JT; Liw YW; Lu YJ; Wong CH; Yu AL; Liang PH
    Chembiochem; 2012 Jul; 13(11):1689-97. PubMed ID: 22730199
    [TBL] [Abstract][Full Text] [Related]  

  • 44. RCAI-61 and related 6'-modified analogs of KRN7000: their synthesis and bioactivity for mouse lymphocytes to produce interferon-γ in vivo.
    Tashiro T; Nakagawa R; Shigeura T; Watarai H; Taniguchi M; Mori K
    Bioorg Med Chem; 2013 Jun; 21(11):3066-79. PubMed ID: 23602521
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The C-glycoside analogue of the immunostimulant alpha-galactosylceramide (KRN7000): synthesis and striking enhancement of activity.
    Yang G; Schmieg J; Tsuji M; Franck RW
    Angew Chem Int Ed Engl; 2004 Jul; 43(29):3818-22. PubMed ID: 15258945
    [No Abstract]   [Full Text] [Related]  

  • 46. Activation of invariant Natural Killer T lymphocytes in response to the α-galactosylceramide analogue KRN7000 encapsulated in PLGA-based nanoparticles and microparticles.
    Macho Fernandez E; Chang J; Fontaine J; Bialecki E; Rodriguez F; Werkmeister E; Krieger V; Ehret C; Heurtault B; Fournel S; Frisch B; Betbeder D; Faveeuw C; Trottein F
    Int J Pharm; 2012 Feb; 423(1):45-54. PubMed ID: 21575695
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and biological activity of hydroxylated analogues of KRN7000 (α-galactosylceramide).
    Shiozaki M; Tashiro T; Koshino H; Shigeura T; Watarai H; Taniguchi M; Mori K
    Carbohydr Res; 2013 Apr; 370():46-66. PubMed ID: 23454137
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The first synthesis of a thioglycoside analogue of the immunostimulant KRN7000.
    Dere RT; Zhu X
    Org Lett; 2008 Oct; 10(20):4641-4. PubMed ID: 18808135
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and biological evaluation of truncated α-galactosylceramide derivatives focusing on cytokine induction profile.
    Toba T; Murata K; Futamura J; Nakanishi K; Takahashi B; Takemoto N; Tomino M; Nakatsuka T; Imajo S; Goto M; Yamamura T; Miyake S; Annoura H
    Bioorg Med Chem; 2012 May; 20(9):2850-9. PubMed ID: 22480852
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 6'-derivatised alpha-GalCer analogues capable of inducing strong CD1d-mediated Th1-biased NKT cell responses in mice.
    Trappeniers M; Van Beneden K; Decruy T; Hillaert U; Linclau B; Elewaut D; Van Calenbergh S
    J Am Chem Soc; 2008 Dec; 130(49):16468-9. PubMed ID: 19554718
    [No Abstract]   [Full Text] [Related]  

  • 51. Effects of 3alpha- and 3beta-galactosylated alpha-galactosylceramides on the immune system.
    Sakai T; Morita M; Matsunaga N; Akimoto K; Yokoyama T; Iijima H; Koezuka Y
    Bioorg Med Chem Lett; 1999 Mar; 9(5):697-702. PubMed ID: 10201831
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A general and stereoselective route to alpha- or beta-galactosphingolipids via a common four-carbon building block.
    Matto P; Modica E; Franchini L; Facciotti F; Mori L; de Libero G; Lombardi G; Fallarini S; Panza L; Compostella F; Ronchetti F
    J Org Chem; 2007 Sep; 72(20):7757-60. PubMed ID: 17784770
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and biological activity of ester and ether analogues of alpha-galactosylceramide (KRN7000).
    Shiozaki M; Tashiro T; Koshino H; Nakagawa R; Inoue S; Shigeura T; Watarai H; Taniguchi M; Mori K
    Carbohydr Res; 2010 Aug; 345(12):1663-84. PubMed ID: 20591421
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Focus on the controversial activation of human iNKT cells by 4-deoxy analogue of KRN7000.
    Lacône V; Hunault J; Pipelier M; Blot V; Lecourt T; Rocher J; Turcot-Dubois AL; Marionneau S; Douillard JY; Clément M; Le Pendu J; Bonneville M; Micouin L; Dubreuil D
    J Med Chem; 2009 Aug; 52(15):4960-3. PubMed ID: 19580320
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis and biological evaluation of α-galactosylceramide analogues with heteroaromatic rings and varying positions of a phenyl group in the sphingosine backbone.
    Kim Y; Oh K; Song H; Lee DS; Park SB
    J Med Chem; 2013 Sep; 56(17):7100-9. PubMed ID: 23919244
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activation of invariant natural killer T cells by synthetic glycolipid ligands suppresses autoantibody-induced arthritis.
    Kaieda S; Tomi C; Oki S; Yamamura T; Miyake S
    Arthritis Rheum; 2007 Jun; 56(6):1836-45. PubMed ID: 17530712
    [TBL] [Abstract][Full Text] [Related]  

  • 57. C-Glycoside analogues of beta-galactosylceramide with a simple ceramide substitute: synthesis and binding to HIV-1 gp120.
    Augustin LA; Fantini J; Mootoo DR
    Bioorg Med Chem; 2006 Feb; 14(4):1182-8. PubMed ID: 16216516
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structure-activity relationship studies of Bz amide-containing α-GalCer derivatives as natural killer T cell modulators.
    Kishi J; Inuki S; Hirata N; Kashiwabara E; Yoshidome D; Ichihara O; Fujimoto Y
    Bioorg Med Chem Lett; 2019 Apr; 29(8):970-973. PubMed ID: 30824201
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis of C-5″ and C-6″-modified α-GalCer analogues as iNKT-cell agonists.
    Guillaume J; Pauwels N; Aspeslagh S; Zajonc DM; Elewaut D; Van Calenbergh S
    Bioorg Med Chem; 2015 Jul; 23(13):3175-82. PubMed ID: 26003341
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Design, synthesis, and functional activity of labeled CD1d glycolipid agonists.
    Jervis PJ; Polzella P; Wojno J; Jukes JP; Ghadbane H; Garcia Diaz YR; Besra GS; Cerundolo V; Cox LR
    Bioconjug Chem; 2013 Apr; 24(4):586-94. PubMed ID: 23458425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.